Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation
- 1 January 2014
- journal article
- Published by Elsevier in Neuroscience
- Vol. 258, 1-15
Abstract
No abstract availableKeywords
Funding Information
- European Molecular Biology Organization
- Bangladesh Council of Scientific and Industrial Research
This publication has 48 references indexed in Scilit:
- Malathion‐induced oxidative stress, cytotoxicity, and genotoxicity in human liver carcinoma (HepG2) cellsEnvironmental Toxicology, 2010
- An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxonToxicology and Applied Pharmacology, 2009
- Poly(ADP-ribosyl)ation in mammalian ageingNucleic Acids Research, 2007
- Differences among cell types in NAD+ compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytesJournal of Neuroscience Research, 2007
- Pharmacological inhibition of PARP-1 reduces α-synuclein- and MPP+-induced cytotoxicity in Parkinson’s disease in vitro modelsBiochemical and Biophysical Research Communications, 2007
- Cholinergic receptor-independent dysfunction of mitochondrial respiratory chain enzymes, reduced mitochondrial transmembrane potential and ATP depletion underlie necrotic cell death induced by the organophosphate poison mevinphosNeuropharmacology, 2006
- The PARP superfamilyBioEssays, 2004
- Caspase Inhibition Extends the Commitment to Neuronal Death Beyond Cytochrome c Release to the Point of Mitochondrial DepolarizationJournal of Cell Biology, 2000
- Alpha-synuclein and Parkinson's diseaseMovement Disorders, 1999
- Carcinogenesis Studies of Dichlorvos in Fischer Rats and B6C3F1 MiceJapanese Journal of Cancer Research, 1991